Award recordCONTRACT

OTSUKA AMERICA PHARMACEUTICAL INC

PIID 36C26022F0016· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $203,334 net obligations· UEI QKABLBMA8FT9· MD

Description

CLOSEOUT MODIFICATION

Base award description: BULK PURCHASE ORDER - TOLVAPTAN (JYNARQUE)

First action · last action
2021-10-01 · 2024-02-28
Transactions
4
First transaction's obligation
$134,876
Base + all options value (sum of deltas)
$203,334
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0099
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$203,370$0Base award · 2021-10-01 · this action $134,876 · running total $134,876Modification P00001 · 2022-05-24 · this action $11,557 · running total $146,433Modification P00002 · 2022-06-13 · this action $56,937 · running total $203,370Modification P00003 · 2024-02-28 · this action -$36 · running total $203,334
  • Base2021-10-01+$134,876= $134,876
  • Mod P000012022-05-24+$11,557= $146,433
  • Mod P000022022-06-13+$56,937= $203,370
  • Mod P000032024-02-28-$36= $203,334
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-10-01+$134,876$134,876BULK PURCHASE ORDER - TOLVAPTAN (JYNARQUE)
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-05-24+$11,557$146,433BULK PURCHASE ORDER - TOLVAPTAN (JYNARQUE)
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-06-13+$56,937$203,370BULK PURCHASE ORDER - TOLVAPTAN (JYNARQUE)
Mod P00003· CLOSE OUT2024-02-28−$36$203,334CLOSEOUT MODIFICATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI QKABLBMA8FT9)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0783245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$20,378FY2026
36C24525N0988245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025
36C24525N0987245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0901245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0789245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0683245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26022F0016_3600_36F79720D0099_3600 · retrieved 2026-09-26.